The Safety of Voriconazole
Open Access
- 15 November 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (10) , 1273-1275
- https://doi.org/10.1086/343746
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patientsClinical Pharmacology & Therapeutics, 2002
- Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: a Dose Escalation StudyThe Journal of Clinical Pharmacology, 2002
- Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in childrenThe Pediatric Infectious Disease Journal, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent FeverNew England Journal of Medicine, 2002
- A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised PatientsClinical Infectious Diseases, 2001